RARE DISEASERESEARCH ATLAS

ORPHA:729224

Epilepsy-mild cortical malformation-oligodendroglial hyperplasia

low confidenceDisorder

Also known as: Mild malformation of cortical development with oligodendroglial hyperplasia and epilepsy · MOGHE

Publications

1,021

Trials

0

Interventional, condition-specific

Researchers

1,261

Distinct authors in sample

Gene link

Readiness

1/6

Stages with a signal

How rare: How common this is has not been clearly measured.

Orphanet entry

Research stages

Trial readiness signals

Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”

1/6 stages with a signal

Research-stage checklist from open sources (GenCC, literature, Monarch when enriched, ClinicalTrials.gov). Not a prognosis or care recommendation.

  1. Gene identifiedNot found

    No GenCC disease–gene assertion in this build

  2. LiteraturePresent

    1,021 matched papers (603 in last 10 years) Source

  3. Phenotype characterisedNot checked

    Not yet enriched from Monarch / HPO

  4. Animal modelNot checked

    Not yet enriched from Monarch / Alliance

  5. Orphan designationNot checked

    FDA/EMA orphan-drug designation not enriched yet

  6. Interventional trialNot found

    No matched interventional trial under our ClinicalTrials.gov rules

Biology

Genes and phenotypes

Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.

Do we know what causes it?

Not yet — the cause hasn't been pinned down in GenCC.

No strong gene–disease assertion joined for this Orphanet entity.

Phenotypes (Monarch / HPO)

Not enriched in this build — Monarch phenotype joins were not run for this record.

Animal models (Monarch / Alliance)

Not enriched in this build.

Literature

Is anyone studying this?

1,021

1,021 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.

1,021 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).

603 in the last 10 years · low confidence

Phrase hits: 1,021 · MeSH hits: 0

Open Europe PMC search

Who's working on it?

1,261

Distinct author names in 200 sampled papers — named people below.

Who's working on it?

No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.

  1. 01
    Blümcke I22 papers · 2026

    Charles Shor Epilepsy Center, Neurological Institute, Cleveland, Ohio, USA.

    Papers in Europe PMC
  2. 02
    Coras R14 papers · 2026

    Department of Neuropathology, Universitätsklinikum Erlangen, Erlangen, Germany.

    Papers in Europe PMC
  3. 03
    Moghe GD14 papers · 2026

    Plant Biology Section, School of Integrative Plant Science, Cornell University, Ithaca, NY, 14853, USA.

    Papers in Europe PMC
  4. 04
    Moghe A13 papers · 2026

    Department of Medicine, Division of Transplant Hepatology, University of Texas Medical Branch, 301 University Boulevard, Galveston, TX, 77555-0655, USA.

    Papers in Europe PMC
  5. 05
    Hartlieb T11 papers · 2026

    Center for Pediatric Neurology, Neurorehabilitation and Epileptology, Schoen-Clinic, 83569 Vogtareuth, Germany.

    Papers in Europe PMC
  6. 06
    Moghe G11 papers · 2026

    Department of Biochemistry and Molecular Biology Michigan State University East Lansing Michigan USA.

    Papers in Europe PMC
  7. 07
    Najm I11 papers · 2026

    Charles Shor Epilepsy Center, Neurological Institute, Cleveland, Ohio, USA.

    Papers in Europe PMC
  8. 08
    Blumcke I10 papers · 2026

    Institute of Neuropathology, University Hospitals Erlangen, Erlangen, Germany.

    Papers in Europe PMC
  9. 09
    Baulac S9 papers · 2024

    Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, APHP, Hôpital de la Pitié Salpêtrière, Paris, France.

    Papers in Europe PMC
  10. 10
    Kobow K9 papers · 2026

    Developmental Neurosciences Programme, UCL NIHR BRC Great Ormond Street Institute of Child Health and Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.

    Papers in Europe PMC

Clinical research

Is a treatment being tested?

0

interventional trials for this specific condition

No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present).

Data as of 27 July 2026

No matched interventional trials. This is true for 73% of diseases in the trials denominator (5114 of 7003). Here are the researchers publishing on it.

low confidence · 36.5th percentile (trials denominator)

Recruiting interventional trials

From the matched ClinicalTrials.gov set

No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.

See who's working on it — people publishing on this disease are often the practical next contact when no trial is listed.

Where to find support

We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:

India — NPRD

Last verified 2026-07-26

This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.

Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.

How we counted this

Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.

"Epilepsy-mild cortical malformation-oligodendroglial hyperplasia" OR "Mild malformation of cortical development with oligodendroglial hyperplasia and epilepsy" OR "Mild malformation of the cortical development with oligodendroglial hyperplasia and epilepsy" OR "MOGHE"

Run this search on Europe PMC

ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):

"Epilepsy-mild cortical malformation-oligodendroglial hyperplasia" OR "Mild malformation of cortical development with oligodendroglial hyperplasia and epilepsy" OR "Mild malformation of the cortical development with oligodendroglial hyperplasia and epilepsy" OR "MOGHE"

Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.

Query health: ok — strategies attempted: phrase; with hits: phrase

Run this search on ClinicalTrials.gov

Confidence reasoning

  • Preferred label is multi-word and distinctive
  • No synonyms dropped by stoplist
  • No label/synonym collisions with other diseases in this corpus
  • No Orphanet definition and no Mondo IDs — likely taxonomy scaffolding; confidence capped at low

Ingested 2026-07-27T21:31:47.998Z